India to Host International Type 1 Diabetes Summit 2026
By Vikas Sir, Founder & Senior Faculty – Cosmo Classes | 24 July 2026
The International Type 1 Diabetes Summit 2026 will be held in Jodhpur, Rajasthan, from 30 July to 1 August 2026. The summit was unveiled at the Constitution Club of India in New Delhi on 23 July 2026 and is being organised through a collaboration involving The Friends of Mewar, Breakthrough T1D, and the William J. Clinton Foundation.
Type 1 diabetes is a chronic autoimmune disease in which the pancreas produces little or no insulin. It usually requires lifelong insulin therapy, regular blood glucose monitoring and clinical follow-up by endocrinologists or diabetes specialists. Unlike Type 2 diabetes, it is primarily an autoimmune condition and not mainly linked to insulin resistance.
The three-day summit will bring together endocrinologists, healthcare professionals, policymakers, researchers and patient advocates from the United States, Australia and India. The main discussion areas include equitable Type 1 diabetes care, insulin access, diabetes technology, mental health support and digital innovation, reflecting a holistic approach to chronic disease management.
The summit connects with national health policy frameworks in India that cover prevention, diagnosis, treatment and access to essential medicines through public health systems. Insulin, first used clinically in 1922, remains the standard treatment for Type 1 diabetes, while modern diabetes technology \u2014 continuous glucose monitors, insulin pumps and digital tracking tools \u2014 is transforming patient care.
Hosting this summit carries significance for India\u2019s health diplomacy and public-health goals. It positions India as a hub for global health dialogue, highlights the need for affordable insulin and equitable care, and can spur domestic innovation and policy attention on non-communicable diseases. The 2027 host city and dates will be announced during the concluding session of the Jodhpur summit, underscoring its role as a recurring global platform.
Important Facts for Exams
- ◆ The International Type 1 Diabetes Summit 2026 will be held in Jodhpur, Rajasthan.
- ◆ Dates: 30 July to 1 August 2026 (three-day summit).
- ◆ It was unveiled at the Constitution Club of India, New Delhi, on 23 July 2026.
- ◆ Organisers: The Friends of Mewar, Breakthrough T1D and the William J. Clinton Foundation.
- ◆ Type 1 diabetes is an autoimmune disease where the pancreas makes little/no insulin.
- ◆ Participants come from the United States, Australia and India.
- ◆ Insulin was first used clinically in 1922 and remains the standard treatment.
Practice Questions (MCQs)
A total of 10 questions — 7 moderate level and 3 UPSC/RPSC level.
Q1. Which city will host the International Type 1 Diabetes Summit 2026?
View Answer
Answer: B – Jodhpur
Explanation: The International Type 1 Diabetes Summit 2026 will be held in Jodhpur, Rajasthan, from 30 July to 1 August 2026.
Q2. Type 1 diabetes is best described as a:
View Answer
Answer: B – Chronic autoimmune disease
Explanation: Type 1 diabetes is a chronic autoimmune disease in which the pancreas produces little or no insulin.
Q3. In Type 1 diabetes, which organ produces little or no insulin?
View Answer
Answer: B – Pancreas
Explanation: In Type 1 diabetes, the pancreas produces little or no insulin, requiring lifelong insulin therapy.
Q4. Where was the summit unveiled on 23 July 2026?
View Answer
Answer: B – Constitution Club of India, New Delhi
Explanation: The summit was unveiled at the Constitution Club of India in New Delhi on 23 July 2026.
Q5. Insulin was first used clinically in which year?
View Answer
Answer: B – 1922
Explanation: Insulin was first used clinically in 1922 and remains the standard treatment for Type 1 diabetes.
Q6. Participants at the summit come from India and which two other countries?
View Answer
Answer: B – United States and Australia
Explanation: The summit brings together participants from the United States, Australia and India.
Q7. How different is Type 1 from Type 2 diabetes?
View Answer
Answer: A – Type 1 is autoimmune; Type 2 is mainly linked to insulin resistance
Explanation: Type 1 diabetes is primarily an autoimmune condition, unlike Type 2, which is mainly linked to insulin resistance.
Q8. Which of the following are focus areas of the summit? (1) Insulin access (2) Diabetes technology (3) Mental health support
View Answer
Answer: D – 1, 2 and 3
Explanation: The summit focuses on equitable care, insulin access, diabetes technology, mental health support and digital innovation.
Q9. Endocrinology, relevant to diabetes care, is the branch of medicine that studies:
View Answer
Answer: B – Hormones and endocrine glands
Explanation: Endocrinology studies hormones and endocrine glands, including the pancreas, which is central to diabetes care.
Q10. When will the 2027 summit\u2019s host city and dates be announced?
View Answer
Answer: B – During the concluding session of the Jodhpur summit
Explanation: The host city and dates for the 2027 summit will be announced during the concluding session of the 2026 Jodhpur summit.
UPSC / RPSC Relevance
- ➜ Prelims: Type 1 diabetes, insulin, endocrinology, summits in news.
- ➜ Mains GS-II: Health policy, non-communicable diseases and access to medicines.
- ➜ Health / S&T: Diabetes technology, digital health and equitable care.
- ➜ Governance: India as a host for global health dialogue and diplomacy.
UPSC Mains Descriptive Question
Non-communicable diseases like Type 1 diabetes pose growing public-health challenges. In light of the International Type 1 Diabetes Summit 2026 hosted by India, discuss the importance of equitable care, insulin access and diabetes technology in India\u2019s health policy. (250 words, 15 marks)
📚 Other Important Categories by Cosmo Classes
Explore more study material, notes and practice questions across our key categories: